ARK Genomic Revolution ETF ARKG
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.75%
- Net assets
- $1.6B
- Holdings
- 33
- 12-month distribution yield
- Unavailable
- Asset class
- Equity
ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund listed on Cboe BZX in the United States, issued by ARK. Its category is Equity · US (equity). Its last price was US$48.65 on 20 Oct 2026. Its expense ratio is 0.75% a year, from its prospectus dated 30 Nov 2025. It reported net assets of US$1.56 billion as of 31 Jul 2026. Its latest holdings report lists 33 holdings as of 31 Jul 2026. No distributions are recorded for it over the last 12 months.
Fees
- Total annual operating expenses (gross)
- 0.75%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.75%
- Prospectus date
- 30 Nov 2025
- Filed with the SEC
- 26 Nov 2025
Size and reporting
- Net assets
- $1,557,225,622
- Total assets
- $1,558,357,006
- Holdings as of
- 31 Jul 2026
- Report made public
- 22 Sep 2026 (53 days after the month end)
Top holdings
Largest 25 of 33 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | 10X GENOMICS INC 10X GENOMICS INC CL A COM | US88025U1097 | 9.39% | $146.3M | Equity (common) | United States | USD |
| 2 | TWIST BIOSCIENCE CORP TWIST BIOSCIENCE CORP COM | US90184D1000 | 7.73% | $120.4M | Equity (common) | United States | USD |
| 3 | TEMPUS AI INC TEMPUS AI INC CL A | US88023B1035 | 6.56% | $102.2M | Equity (common) | United States | USD |
| 4 | CRISPR THERAPEUTICS AG CRISPR THERAPEUTICS AG NAMEN AKT | CH0334081137 | 6.29% | $97.9M | Equity (common) | Switzerland | USD |
| 5 | PERSONALIS INC PERSONALIS INC COM | US71535D1063 | 5.47% | $85.3M | Equity (common) | United States | USD |
| 6 | ABSCI CORP ABSCI CORP COM | US00091E1091 | 5.14% | $80.0M | Equity (common) | United States | USD |
| 7 | GUARDANT HEALTH INC GUARDANT HEALTH INC COM | US40131M1099 | 4.74% | $73.8M | Equity (common) | United States | USD |
| 8 | ILLUMINA INC ILLUMINA INC COM | US4523271090 | 4.74% | $73.8M | Equity (common) | United States | USD |
| 9 | ELI LILLY & COMPANY ELI LILLY & COMPANY COM | US5324571083 | 4.68% | $73.0M | Equity (common) | United States | USD |
| 10 | CAREDX INC CAREDX INC COM | US14167L1035 | 4.30% | $66.9M | Equity (common) | United States | USD |
| 11 | NATERA INC NATERA INC COM | US6323071042 | 4.13% | $64.3M | Equity (common) | United States | USD |
| 12 | BEAM THERAPEUTICS INC BEAM THERAPEUTICS INC COM | US07373V1052 | 3.78% | $58.8M | Equity (common) | United States | USD |
| 13 | COMPASS PATHWAYS PLC COMPASS PATHWAYS PLC SPONSORED ADS | US20451W1018 | 3.25% | $50.7M | Equity (common) | United Kingdom | USD |
| 14 | RECURSION PHARMACEUTICALS INC RECURSION PHARMACEUTICALS INC CL A | US75629V1044 | 2.63% | $40.9M | Equity (common) | United States | USD |
| 15 | ADAPTIVE BIOTECHNOLOGIES CORP ADAPTIVE BIOTECHNOLOGIES CORP COM | US00650F1093 | 2.57% | $40.1M | Equity (common) | United States | USD |
| 16 | VERACYTE INC VERACYTE INC COM | US92337F1075 | 2.55% | $39.7M | Equity (common) | United States | USD |
| 17 | NURIX THERAPEUTICS INC NURIX THERAPEUTICS INC COM | US67080M1036 | 2.51% | $39.0M | Equity (common) | United States | USD |
| 18 | BUTTERFLY NETWORK INC BUTTERFLY NETWORK INC COM CL A | US1241551027 | 2.18% | $33.9M | Equity (common) | United States | USD |
| 19 | SCHRODINGER INC SCHRODINGER INC COM | US80810D1037 | 1.99% | $30.9M | Equity (common) | United States | USD |
| 20 | GENEDX HOLDINGS CORP GENEDX HOLDINGS CORP COM CL A | US81663L2007 | 1.87% | $29.1M | Equity (common) | United States | USD |
| 21 | INTELLIA THERAPEUTICS INC INTELLIA THERAPEUTICS INC COM | US45826J1051 | 1.83% | $28.5M | Equity (common) | United States | USD |
| 22 | IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC COM | US4622221004 | 1.77% | $27.5M | Equity (common) | United States | USD |
| 23 | ALAMAR BIOSCIENCES INC ALAMAR BIOSCIENCES INC COMMON STOCK | US0109111056 | 1.56% | $24.3M | Equity (common) | United States | USD |
| 24 | PRIME MEDICINE INC PRIME MEDICINE INC COM | US74168J1016 | 1.41% | $21.9M | Equity (common) | United States | USD |
| 25 | GENERATE BIOMEDICINES INC GENERATE BIOMEDICINES INC COM SHS | US3709201004 | 1.11% | $17.3M | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.63% | |
| Short-term investment vehicles (cash funds) | 0.18% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 90.27% | |
| Switzerland | 6.29% | |
| United Kingdom | 3.25% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 99.81% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 24.56% | |
| Technology | 6.56% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- Unavailable
- 12-month yield
- Unavailable
- Frequency
- None in 12 months
- Latest ex-date
- Unavailable
12-month yield = distributions per unit with an ex-date in the last 12 months ÷ latest price × 100. It is not shown because there were no distributions in the last 12 months.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (1 payments)
| Ex-date | Amount per unit |
|---|---|
| 29 Dec 2021 | $0.3820 |
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000042975) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- ARKG and VTI Vanguard Morningstar Total Stock Market ETF
- ARKG and VOO Vanguard S&P 500 ETF
- ARKG and IVV iShares Core S&P 500 ETF
- ARKG and QQQ Invesco QQQ Trust, Series 1